Australia markets closed

Surgery Partners, Inc. (SGRY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
34.33-1.08 (-3.05%)
At close: 04:00PM EST
35.01 +0.68 (+1.98%)
After hours: 06:13PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 4.41B
Enterprise value 7.78B
Trailing P/E N/A
Forward P/E 54.95
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.24
Price/book (mrq)3.62
Enterprise value/revenue 3.18
Enterprise value/EBITDA 16.42

Trading information

Stock price history

Beta (5Y monthly) 2.71
52-week change 3-25.39%
S&P500 52-week change 3-9.08%
52-week high 363.87
52-week low 320.46
50-day moving average 329.02
200-day moving average 332.48

Share statistics

Avg vol (3-month) 3902k
Avg vol (10-day) 3598.96k
Shares outstanding 5122.6M
Implied shares outstanding 6N/A
Float 844.72M
% held by insiders 11.41%
% held by institutions 191.70%
Shares short (12 Jan 2023) 45.04M
Short ratio (12 Jan 2023) 47.71
Short % of float (12 Jan 2023) 48.19%
Short % of shares outstanding (12 Jan 2023) 44.11%
Shares short (prior month 14 Dec 2022) 44.3M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin -1.28%
Operating margin (ttm)14.27%

Management effectiveness

Return on assets (ttm)3.58%
Return on equity (ttm)4.95%

Income statement

Revenue (ttm)2.44B
Revenue per share (ttm)27.88
Quarterly revenue growth (yoy)11.00%
Gross profit (ttm)491.4M
EBITDA 456.5M
Net income avi to common (ttm)-31.3M
Diluted EPS (ttm)-0.47
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)154.8M
Total cash per share (mrq)1.75
Total debt (mrq)3.57B
Total debt/equity (mrq)146.04
Current ratio (mrq)1.18
Book value per share (mrq)13.28

Cash flow statement

Operating cash flow (ttm)171.3M
Levered free cash flow (ttm)83.79M